Cardiac safety is the #1 reason for drug development failure & post-market recalls.
High-quality data and reporting are essential to drive decisions in both site-based and DCTs from Phase 1 to Phase IV. As the most trusted name in cardiac safety with 50 years of experience, Clario centralizes the approach to data collection with rigorous, responsive and reliable tools that deliver credible, compliant, high-quality data you can be certain of.
Our goal is always to:
- Improve patient safety and enrollment
- Increase data access leading to reduced timelines
- Deliver scientific-grade data to reduce variability
- Solutions with the patients in mind
Regardless of therapeutic area or where your data is coming from, Clario helps you collect reliable evidence with certainty—in site-based and DCT environments— enabling you to bring new drugs and therapies to market. Learn how our solutions and scientific experts can help you effectively pitch, expertly design and efficiently implement successful cardiac safety data for your submission.
Available solutions
Arrhythmia Analysis
Collect continuous ECG data with certainty in site-based or decentralized clinical trials with our flexible technology solutions and patient-friendly devices.
Blood Pressure Services
Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to decentralized trials.
ECG — On-site to DCT and Phase I-IV
Monitor every heartbeat with precision from anywhere to ensure safety throughout your site-based or decentralized clinical trial.
Phase I/TQT Cardiac Assessment
Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial by collaborating with our Phase 1 Center of Excellence.
Regulatory Consultation and Statistical Analysis Expertise
Leverage our industry key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.
Proven results earn trust
13,887
Trials supported
580
New drug approvals
50
Years science
600+
QT studies
200+
Combined years of clinical experience
480+
Unique programs
87+
Approvals from TQTS alone
230+
Sponsors
Cardiac Safety Science Team
Robert Kleiman, MD
VP & Chief Medical Officer, Cardiology
Borje Darpo, MD, PhD
Chief Scientific Officer, Cardiac Safety
Joel Morganroth, MD
Chief Scientific Advisor, Cardiac Safety
Mori J. Krantz, MD, FACP, FACC
Senior Cardiologist & Chief Science Advisor Cardiac Safety and Cardiovascular Imaging
Peem Lorvidhaya, MD
Senior Director, Cardiology
Bruce Lloyd, MD
Medical Director
Onglee Weng, MBA, MD
Vice President, General Manager, Clario Shanghai
Jean T. Barbey, MD
Expert Cardiac Safety Medical Advisor
Jeff Heilbraun, MS
Vice President, Medical and Scientific Affairs, Cardiology
Luc Dekie, PhD
Director Scientific Affairs, Cardiology
Increase confidence in site performance with Clario Certified Sites.
Clario Certified Sites have completed our Certified Site program to ensure that each study is conducted in an optimal manner and results in the highest quality data. The certification program requires each site to go through an extensive training and testing process. These sites help sponsors reduce study start-up time with well-trained and well-equipped sites.
Learn more or speak with one of our experts
Our team of clinical trial cardiac safety experts are always available to address questions about our cardiac safety solutions. Submit your contact information and we’ll be in touch shortly.